# Frontida Biopharm, LLC – FDA Inspection, Feb 26, 2021

Source: https://www.keypedia.com/records/fda_inspections/frontida-biopharm-llc/95354c58-9f97-48e1-9f28-5f91a3cabce0
Source feed: FDA_Inspections

> FDA inspection 1137467 of Frontida Biopharm, LLC, February 26, 2021. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1137467
- Company Name: Frontida Biopharm, LLC
- Inspection Date: 2021-02-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1283762 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-llc/e7bdf618-1f6a-4a66-b243-95bdbeb8f6c8)
- FDA Inspection 961359 - 2016-02-18
- FDA Inspection 820917 - 2013-02-26
- FDA Inspection 739828 - 2011-08-16
- FDA Inspection 637304 - 2010-01-05

Company: https://www.keypedia.com/companies/frontida-biopharm-llc/cf64a5c6-28c6-49c7-b4d2-b12b1339c2e5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
